Rockefeller Capital Management
RCUS icon

Rockefeller Capital Management’s Arcus Biosciences RCUS Stock Holding History

Rockefeller Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Sell
12,732
-197
-2% -$4.87K ﹤0.01% 2218
2026
Q1 		$279K Buy
12,929
+705
+6% +$15.2K ﹤0.01% 2298
2025
Q4 		$291K Buy
12,224
+8,368
+217% +$171K ﹤0.01% 2172
2025
Q3 		$52.4K Buy
+3,856
New +$40.1K ﹤0.01% 2891
2023
Q1 		– Sell
-8,596
Closed -$177K – 3473
2022
Q4 		$177K Hold
8,596
– – ﹤0.01% 1720
2022
Q3 		$224K Sell
8,596
-129
-1% -$3.41K ﹤0.01% 1603
2022
Q2 		$220K Buy
+8,725
New +$214K ﹤0.01% 1597

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Rockefeller Capital Management's RCUS Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Arcus Biosciences (RCUS) stake by 1.5% in Q2 2026, selling an estimated $4.87K and leaving 12,732 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #2218.

Rockefeller Capital Management first reported a position in RCUS in Q2 2022 and has held it in 7 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Rockefeller Capital Management held 12,732 shares of Arcus Biosciences worth $393K as of Q2 2026.
  • Rockefeller Capital Management sold 197 Arcus Biosciences shares in Q2 2026, an estimated $4.87K.
  • Arcus Biosciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2218 holding.
  • Rockefeller Capital Management first reported a position in Arcus Biosciences in Q2 2022 and has held it in 7 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.